Medicinal Plant Research 2024, Vol.14, No.3, 151-161 http://hortherbpublisher.com/index.php/mpr 156 6 Case Study 6.1 Clinical trials on the efficacy of peppermint tea Several clinical trials have investigated the efficacy of peppermint tea and peppermint oil in treating various conditions, particularly focusing on digestive disorders such as irritable bowel syndrome (IBS). A systematic review and meta-analysis identified that peppermint essential oil is both efficacious and well-tolerated in the short-term management of IBS symptoms (Hawrelak et al., 2019). Another randomized controlled trial found that small intestinal-release peppermint oil significantly reduced abdominal pain, discomfort, and IBS severity compared to placebo, although it did not meet the primary endpoints for overall symptom relief (Weerts et al., 2019). Additionally, a network meta-analysis ranked peppermint oil as the most effective treatment for global IBS symptoms among traditional therapies, including soluble fiber and antispasmodic drugs. 6.2 Safety studies in diverse populations Safety studies have shown that peppermint oil and peppermint tea are generally well-tolerated across different populations. A systematic review focusing on children and adolescents with gastrointestinal disorders found that peppermint oil effectively decreased the duration, frequency, and severity of pain in children suffering from undifferentiated functional abdominal pain, with no serious adverse events reported (Anheyer et al., 2017). Another study on healthy volunteers consuming peppermint tea for six days found that while peppermint tea may alter the pharmacokinetics of clinically administered drugs, it did not significantly affect the activities of several metabolizing enzymes, indicating a favorable safety profile. Furthermore, a randomized controlled trial on breast cancer patients undergoing chemotherapy demonstrated that peppermint extract significantly reduced the severity of nausea, vomiting, and anorexia without any severe adverse effects (Figure 2) (Jafarimanesh et al., 2020). The study of Jafarimanesh et al. (2020) illustrates the effects of an intervention on nausea, anorexia, and vomiting severity over four time points. In the intervention group, there is a noticeable reduction in symptoms compared to the control group, particularly after chemotherapy. Nausea and anorexia severity peaked and then decreased in both groups, with the intervention group showing a faster and more pronounced reduction. The frequency of vomiting episodes remained lower in the intervention group throughout the study, demonstrating the potential effectiveness of the intervention in alleviating chemotherapy-related gastrointestinal distress. 6.3 Long-term health benefits observed in peppermint tea consumers Long-term consumption of peppermint tea has been associated with various health benefits. The inhibition of NAT2 enzyme activity observed in a study on healthy volunteers suggests that regular intake of peppermint tea may contribute to cancer chemoprevention (Begas et al., 2017). Additionally, the broad spectrum of bioactive phytochemicals in peppermint, such as flavonoids and phenolics, provides antioxidant, anti-inflammatory, and antimicrobial effects, which can contribute to overall health and well-being (Mahendran and Rahman, 2020). While most clinical trials focus on short-term outcomes, the consistent findings of symptom relief and safety across different studies suggest that long-term consumption of peppermint tea could offer sustained health benefits, particularly for digestive health and symptom management in conditions like IBS (Black et al., 2019). By integrating these findings, it becomes evident that peppermint tea and peppermint oil hold significant promise in modern herbal medicine, particularly for their digestive benefits and potential long-term health advantages.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==